UNSPSC 51182024: Danazol

This classification denotes a therapeutic androgen, gonadotropin releasing hormone inhibitor, and anabolic steroid with the molecular formula C22H27NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N29QWW3BUO, chemically known as win 17,757 but generally known as danazol, which bears US NIH Compound Identifier 2949. European Medicines Agency schedules Danazol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06897MIG. The term DANAZOL is an International Non-Proprietary Name.

UNSPSC 51182024 Danazol, a Commodity code, covers the supply of specific pharmaceutical active ingredients and finished-dose products to state and local government facilities. Recent state and local activity under this code centers on generic multi-source pharmaceuticals procurement through cooperative purchasing agreements. State procurement offices and multistate cooperative alliances are the primary buyers, with the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) representing a significant and repeat user of this taxonomy for pharmaceutical supply contracts serving multiple member jurisdictions across states including Minnesota and Oregon.

The Minnesota Department of Administration's Office of State Procurement, acting through MMCAP, issued a Request for Proposal (RFP S1070000015802) on January 20, 2026, with proposals due March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products. Vendors must supply through three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC), maintain relationships with at least two of the three, comply with current Good Manufacturing Practices and the Drug Supply Chain Security Act, and submit pricing in flat price, net price, or WAC-minus formats. The contract term is two years for new vendors with optional extensions, effective July 1, 2026. Evaluation weights pricing competitiveness at 75 percent, with the remaining 25 percent distributed across fixed pricing, administrative compliance, EDI capability, and agreement to a 3 percent administrative fee. Vendors must carry commercial general liability insurance of $5,000,000 per occurrence and network security and privacy liability of $2,000,000, with performance penalties of $200 to $1,500 per violation for reporting or onboarding failures. No specific award value or budget range was disclosed in the solicitation materials.